Logo image of LXU

LSB INDUSTRIES INC (LXU) Stock Fundamental Analysis

USA - NYSE:LXU - US5021601043 - Common Stock

8.38 USD
+0.24 (+2.95%)
Last: 9/18/2025, 4:10:03 PM
8.38 USD
0 (0%)
After Hours: 9/18/2025, 4:10:03 PM
Fundamental Rating

3

Taking everything into account, LXU scores 3 out of 10 in our fundamental rating. LXU was compared to 83 industry peers in the Chemicals industry. The financial health of LXU is average, but there are quite some concerns on its profitability. LXU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

LXU had positive earnings in the past year.
LXU had a positive operating cash flow in the past year.
In multiple years LXU reported negative net income over the last 5 years.
Of the past 5 years LXU 4 years had a positive operating cash flow.
LXU Yearly Net Income VS EBIT VS OCF VS FCFLXU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.94%, LXU is doing worse than 67.47% of the companies in the same industry.
LXU has a worse Return On Equity (-6.69%) than 66.27% of its industry peers.
Industry RankSector Rank
ROA -2.94%
ROE -6.69%
ROIC N/A
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)N/A
ROIC(5y)N/A
LXU Yearly ROA, ROE, ROICLXU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

In the last couple of years the Operating Margin of LXU has declined.
LXU has a Gross Margin of 7.11%. This is amonst the worse of the industry: LXU underperforms 87.95% of its industry peers.
LXU's Gross Margin has improved in the last couple of years.
LXU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.11%
OM growth 3Y-59.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
LXU Yearly Profit, Operating, Gross MarginsLXU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

LXU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LXU has been reduced compared to 1 year ago.
The number of shares outstanding for LXU has been increased compared to 5 years ago.
LXU has a better debt/assets ratio than last year.
LXU Yearly Shares OutstandingLXU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXU Yearly Total Debt VS Total AssetsLXU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

LXU has an Altman-Z score of 1.46. This is a bad value and indicates that LXU is not financially healthy and even has some risk of bankruptcy.
LXU has a worse Altman-Z score (1.46) than 69.88% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that LXU is somewhat dependend on debt financing.
LXU has a worse Debt to Equity ratio (0.91) than 61.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 1.46
ROIC/WACCN/A
WACC9.05%
LXU Yearly LT Debt VS Equity VS FCFLXU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

LXU has a Current Ratio of 2.64. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.64, LXU is in the better half of the industry, outperforming 72.29% of the companies in the same industry.
A Quick Ratio of 2.05 indicates that LXU has no problem at all paying its short term obligations.
LXU has a better Quick ratio (2.05) than 78.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.05
LXU Yearly Current Assets VS Current LiabilitesLXU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.24% over the past year.
LXU shows a small growth in Revenue. In the last year, the Revenue has grown by 2.60%.
Measured over the past years, LXU shows a small growth in Revenue. The Revenue has been growing by 7.43% on average per year.
EPS 1Y (TTM)17.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.17%
Revenue 1Y (TTM)2.6%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%8.01%

3.2 Future

LXU is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.59% yearly.
Based on estimates for the next years, LXU will show a small growth in Revenue. The Revenue will grow by 3.95% on average per year.
EPS Next Y-19.74%
EPS Next 2Y-17.21%
EPS Next 3Y2.38%
EPS Next 5Y1.59%
Revenue Next Year14.66%
Revenue Next 2Y7.06%
Revenue Next 3Y5.96%
Revenue Next 5Y3.95%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LXU Yearly Revenue VS EstimatesLXU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
LXU Yearly EPS VS EstimatesLXU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LXU is valuated rather expensively with a Price/Earnings ratio of 24.65.
LXU's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.20, LXU is valued at the same level.
LXU is valuated rather expensively with a Price/Forward Earnings ratio of 21.83.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LXU is on the same level as its industry peers.
LXU's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 24.65
Fwd PE 21.83
LXU Price Earnings VS Forward Price EarningsLXU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as LXU.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.13
LXU Per share dataLXU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.21%
EPS Next 3Y2.38%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LXU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LSB INDUSTRIES INC

NYSE:LXU (9/18/2025, 4:10:03 PM)

After market: 8.38 0 (0%)

8.38

+0.24 (+2.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners54.36%
Inst Owner Change4.09%
Ins Owners4.21%
Ins Owner Change0.3%
Market Cap602.86M
Analysts75
Price Target8.99 (7.28%)
Short Float %3.29%
Short Ratio4.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.88%
Min EPS beat(2)-33.99%
Max EPS beat(2)69.76%
EPS beat(4)3
Avg EPS beat(4)67.73%
Min EPS beat(4)-33.99%
Max EPS beat(4)135.15%
EPS beat(8)5
Avg EPS beat(8)38.25%
EPS beat(12)7
Avg EPS beat(12)19.05%
EPS beat(16)10
Avg EPS beat(16)40.13%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-4.79%
Max Revenue beat(2)6.25%
Revenue beat(4)3
Avg Revenue beat(4)6.96%
Min Revenue beat(4)-4.79%
Max Revenue beat(4)13.55%
Revenue beat(8)6
Avg Revenue beat(8)4.28%
Revenue beat(12)9
Avg Revenue beat(12)4.2%
Revenue beat(16)11
Avg Revenue beat(16)3.01%
PT rev (1m)0%
PT rev (3m)1.53%
EPS NQ rev (1m)10%
EPS NQ rev (3m)633.33%
EPS NY rev (1m)34.85%
EPS NY rev (3m)85.42%
Revenue NQ rev (1m)-12.54%
Revenue NQ rev (3m)11.87%
Revenue NY rev (1m)1.82%
Revenue NY rev (3m)4.86%
Valuation
Industry RankSector Rank
PE 24.65
Fwd PE 21.83
P/S 1.12
P/FCF N/A
P/OCF 13.08
P/B 1.22
P/tB 1.22
EV/EBITDA 10.13
EPS(TTM)0.34
EY4.06%
EPS(NY)0.38
Fwd EY4.58%
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)0.64
OCFY7.64%
SpS7.49
BVpS6.89
TBVpS6.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.94%
ROE -6.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.11%
FCFM N/A
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.64%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-59.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA 5.75
Cap/Depr 124.63%
Cap/Sales 18.3%
Interest Coverage N/A
Cash Conversion 58.81%
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.05
Altman-Z 1.46
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)96.58%
Cap/Depr(5y)76.59%
Cap/Sales(3y)11.38%
Cap/Sales(5y)9.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.17%
EPS Next Y-19.74%
EPS Next 2Y-17.21%
EPS Next 3Y2.38%
EPS Next 5Y1.59%
Revenue 1Y (TTM)2.6%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%8.01%
Revenue Next Year14.66%
Revenue Next 2Y7.06%
Revenue Next 3Y5.96%
Revenue Next 5Y3.95%
EBIT growth 1Y-103.81%
EBIT growth 3Y-60.57%
EBIT growth 5YN/A
EBIT Next Year2179.64%
EBIT Next 3Y189.92%
EBIT Next 5Y92.67%
FCF growth 1Y-131.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.77%
OCF growth 3Y-0.4%
OCF growth 5Y110.4%